Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.86% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
SBGI · Mar 31, 2026
Sinclair, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001971213-26-000025General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.33% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
3.99% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
3.35% · CORE · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.60% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History6 statesHistory building
Period transition
What moved in the state?
- Previous
- 2.34%
- Current
- 1.86%
- Delta
- -0.48%
- Previous
- 5.96%
- Current
- 5.33%
- Delta
- -0.64%
- Previous
- -10.68%
- Current
- 3.99%
- Delta
- 14.68%
- Previous
- 5.46%
- Current
- 3.35%
- Delta
- -2.11%
- Previous
- 1.61%
- Current
- 2.60%
- Delta
- 0.99%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · SBGI Fundamental State →Has State · Sinclair, Inc. →Transitioned To · SBGI Fundamental State →Transitioned To · SBGI CAPEX_INTENSITY_DECREASED →Transitioned To · SBGI CASH_GENERATION_DECREASED →Transitioned To · SBGI GROWTH_INCREASED →Transitioned To · SBGI PROFITABILITY_DECREASED →Transitioned To · SBGI SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.